drug · small molecule
patient view →infigratinib phosphate
Marketedupdated 2mo agoby QED Therapeutics Inc🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for cholangiocarcinoma and 1 investigational indication.
targets
Fibroblast growth factor receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that